Xu et al. recently found that MEL had a therapeutic effect in advanced age‐related macular degeneration (AMD) by inhibiting macrophage polarization to M2 cells and simultaneously promoting it to M1 cells through RhoA/ROCK signaling pathway.32 The gene discussed is RHOA; the disease is age-related macular degeneration.